Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Boston Scientific Corporation
This study is a prospective, randomized, open-label, triple-arm, multi-center trial. Subjects will be randomized 1:1:1 to one of the three therapy arms and remain on treatment through the end of study (12 months): 1. Aspirin only 2. Reduced dose non-vitamin K antagonist (VKA) oral anticoagulant (NOAC) 3. DAPT
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted